Optimus Healthcare Services, Inc. (OHCS)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
At close: Jan 21, 2026

OHCS Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Revenue
1.821.51.220.831.091.14
Revenue Growth (YoY)
43.68%22.88%47.34%-23.80%-4.74%-
Cost of Revenue
0.260.280.260.110.210.29
Gross Profit
1.561.210.960.720.880.85
Selling, General & Admin
4.085.325.713.761.261.16
Operating Expenses
6.029.799.028.461.261.16
Operating Income
-4.46-8.57-8.07-7.74-0.38-0.31
Interest Expense
-1.63-1.77-1.46-0.82-0.01-0.01
Interest & Investment Income
0.010.0900.02--
EBT Excluding Unusual Items
-6.07-10.25-9.52-8.55-0.39-0.33
Impairment of Goodwill
-0.82-0.82----
Gain (Loss) on Sale of Investments
---0.18-0.02--
Gain (Loss) on Sale of Assets
-0.04-0.04-0.13---
Other Unusual Items
-0.26--0.220.150.13-
Pretax Income
-7.19-11.1-10.05-8.42-0.27-0.33
Income Tax Expense
000.67-0.67--
Earnings From Continuing Operations
-7.19-11.1-10.73-7.75-0.27-0.33
Minority Interest in Earnings
00000.120.16
Net Income
-7.19-11.1-10.72-7.75-0.15-0.17
Net Income to Common
-7.19-11.1-10.72-7.75-0.15-0.17
Shares Outstanding (Basic)
444039178-
Shares Outstanding (Diluted)
444039178-
Shares Change (YoY)
9.16%3.05%128.24%111.41%--
EPS (Basic)
-0.16-0.28-0.28-0.46-0.02-
EPS (Diluted)
-0.16-0.28-0.28-0.46-0.02-
Free Cash Flow
-0.8-3.72-4.09-2.76-0.260.01
Free Cash Flow Per Share
-0.02-0.09-0.11-0.16-0.03-
Gross Margin
85.71%81.01%78.45%86.86%81.04%74.23%
Operating Margin
-245.11%-572.37%-661.77%-935.59%-35.17%-27.28%
Profit Margin
-395.38%-741.19%-879.89%-937.04%-13.82%-14.58%
Free Cash Flow Margin
-43.97%-248.51%-335.95%-333.52%-23.78%0.70%
EBITDA
-4.44-8.56-8.06-7.43-0.38-0.31
EBITDA Margin
-244.26%----35.15%-27.26%
D&A For EBITDA
0.020.0200.3100
EBIT
-4.46-8.57-8.07-7.74-0.38-0.31
EBIT Margin
-245.11%----35.17%-27.28%
Advertising Expenses
-0.010.05---
Source: S&P Capital IQ. Standard template. Financial Sources.